Lundbeckfond Invest A/S 3
3 · Trevi Therapeutics, Inc. · Filed May 7, 2019
Insider Transaction Report
Form 3
Lundbeckfond Invest A/S
10% Owner
Holdings
Series C Preferred Stock
→ Common Stock (776,307 underlying)
Footnotes (1)
- [F1]The Series C Preferred Stock and the dividends that have accrued thereon to date are convertible on a 9.5-for-one basis into the number of shares of Common Stock shown in Column 3 without payment of further consideration at the holder's election or automatically upon the closing of the Issuer's initial public offering. The number of shares of Common Stock into which the Series C Preferred Stock and accrued dividends thereon are convertible will increase on a daily basis without payment of further consideration as additional dividends accrue. The shares have no expiration date.